There is strong evidence that CRT reduces mortality and hospitalization and improves cardiac function in this symptomatic HFrEF.
Indeed, comprehensive evaluation beforehand is interesting to be discussed, meet us at #ihefcard2023
Joint sympo @inaHFCarmet and @inahrs
We assembled an amazing line up of renowned international speakers on Heart Failure only for you.
Sign up right away by clicking https://t.co/g3hcdao16J and follow simple effortless steps.
Best,
Your Third i-HefCard 2023
Multiparametric quantification of congestion using clinical parameters, non invasive imaging techniques, and biomarkers is needed especially to face residual congestion.
Learn more about congestion in #ihefcard2023. Find everything you need at https://t.co/Qc3Lc9U8wF.
🆕 ACC Expert Consensus Decision Pathway on the Management of #HFpEF addresses diagnostic challenges tied to EF threshold, correct terminology, gender/sex differences, & the lack of a single test that definitively establishes Dx. https://t.co/ION8LWROpl
#JACC#CardioTwitter
HFpEF is an increasingly common cause of exercise intolerance linked to #obesity & sedentary behavior. Despite advances in understanding of pathophysiological mechanisms, Dx, & Tx, #HFpEF remains under-recognized. Further research is needed! https://t.co/2Jjeu1ah4d #JACC#SGLT2i
What should be the targets for success in treatment of patients hospitalized for HF? Weight loss achieved during hospitalization is driven partly by the expected length of stay, not by clinical targets. We should individualize targets https://t.co/JIFgB5Jtoc @JACCJournals#JACCHF
Out in @JCardFail, our state-of-the-art review discusses the management of #HF in patients on dialysis.
Immensely grateful to Dr.@ShahzebKhanMD for the invaluable guidance and opportunity to work with leading co-authors in the field.
https://t.co/BgNFKQttQM
Kicking off the year with our first tweet. Our summer survival series noon conference is now in full swing. Great lecture yesterday by @AmirMasoumiMD on cardiogenic shock. Here’s an awesome infographic by @CardioNerds@a_h_ghoneem. Spreading the knowledge. #MedTwitter#MedEd
Included in the 2022 AHA/ACC/HFSA Guideline for the Management of #HeartFailure are Value Statements for select interventions with high-quality, published evidence on cost-effectiveness. See the recommendations for high-quality care, summarized in our #infographic below!
It's a failure, a real failure 🥲. A 15 years "old" aortic mechanical valve on rheumatic heart disease, without proper anticoagulant and long-term antibiotic 🥲. He came with full blown acute pulmonary edema and no metallic sound..
#TipsForNewDocs
HF patient:
Wrong: "No rales- switch to oral diuretics!"
Right: "JVP elevated- continue IV diuresis!"
Worst way to assess volume status: rales. They're often absent in chronic HF due to pulmonary lymphatic compensation.
#kittlesonrules
In this post hoc analysis of the DAPA-HF trial including 4,744 patients with #HFrEF;
#Dapagliflozin ⬇️ the risk of worsening HF or CV ☠️ across the range of a modified treatment score, integrating classes and doses of #GDMT , developed by the HFC https://t.co/Abz9w6GaHu #JACCHF